Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov;3(5):204-14.
doi: 10.1159/000343487. Epub 2012 Oct 12.

Molecular genetics of charcot-marie-tooth disease: from genes to genomes

H Azzedine  1 , J Senderek, C Rivolta, R Chrast
Affiliations

Molecular genetics of charcot-marie-tooth disease: from genes to genomes

H Azzedine et al. Mol Syndromol. 2012 Nov.

Abstract

Charcot-Marie-Tooth disease (CMT) is a heterogeneous group of disorders of the peripheral nervous system, mainly characterized by distal muscle weakness and atrophy leading to motor handicap. With an estimated prevalence of 1 in 2,500, this condition is one of the most commonly inherited neurological disorders. Mutations in more than 30 genes affecting glial and/or neuronal functions have been associated with different forms of CMT leading to a substantial improvement in diagnostics of the disease and in the understanding of implicated pathophysiological mechanisms. However, recent data from systematic genetic screening performed in large cohorts of CMT patients indicated that molecular diagnosis could be established only in ∼50-70% of them, suggesting that additional genes are involved in this disease. In addition to providing an overview of genetic and functional data concerning various CMT forms, this review focuses on recent data generated through the use of highly parallel genetic technologies (SNP chips, sequence capture and next-generation DNA sequencing) in CMT families, and the current and future impact of these technologies on gene discovery and diagnostics of CMTs.

Keywords: Charcot-Marie-Tooth disease; Medical genetics; Next-generation sequencing.

PubMed Disclaimer

References

    1. Abrams CK, Freidin M, Bukauskas F, Dobrenis K, Bargiello TA, et al. Pathogenesis of X-linked Charcot-Marie-Tooth disease: differential effects of two mutations in connexin 32. J Neurosci. 2003;23:10548–10558. - PMC - PubMed
    1. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet. 1995;11:274–280. - PubMed
    1. Almeida-Souza L, Asselbergh B, d'Ydewalle C, Moonens K, Goethals S, et al. Small heat-shock protein HSPB1 mutants stabilize microtubules in Charcot-Marie-Tooth neuropathy. J Neurosci. 2011;31:15320–15328. - PMC - PubMed
    1. Antonellis A, Ellsworth RE, Sambuughin N, Puls I, Lee-Lin SQ, et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet. 2003;72:1293–1299. - PMC - PubMed
    1. Anzini P, Neuberg DH, Schachner M, Nelles E, Willecke K, et al. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J Neurosci. 1997;17:4545–4551. - PMC - PubMed